Business Context and Reporting Period
This Form 8-K Current Report was filed by Eli Lilly and Company on September 5, 2024, regarding events occurring on September 9, 2024. The filing focuses on corporate governance changes, specifically the appointment of a new Chief Financial Officer.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It is a current report regarding personnel changes rather than a financial results statement.
Material Changes
The primary material change is the election of Lucas Montarce as Executive Vice President and Chief Financial Officer, effective September 9, 2024. Mr. Montarce, age 47, has been with the company since 2001 and most recently served as President and General Manager for the Spain, Portugal, and Greece hub.
Management Commentary and Compensation
In connection with his new role, Mr. Montarce will receive an annualized base salary of $1,000,000 and is eligible for an annualized target bonus of $1,000,000. The Board conducted an internal and external search for the position. The filing states there are no family relationships between Mr. Montarce and any director or executive officer, and no arrangements subject to Section 404(a) of Regulation S-K.
Investor Verification Checklist
- Verify the effective date of the CFO transition (September 9, 2024).
- Confirm the total annualized compensation package ($2,000,000 combined base and target bonus).
- Review the attached press release (Exhibit 99.1) for additional strategic context.
- Note that this filing contains no financial performance data; refer to the most recent 10-Q or 10-K for financial metrics.